-
Niva Bupa Health
82.00 61.01(%) -
Reliance Power
62.80 60.50(%) -
Max Healthcare
1,156.00 1,227.50(%) -
Mazagon Dock
3,380.35 1,200.00(%) -
Garden Reach Sh.
2,875.00 1,148.10(%) -
Suzlon Energy
73.44 86.04(%) -
Yes Bank
22.86 27.41(%) -
St Bk of India
818.50 912.10(%) -
Inox Wind
189.50 124.35(%) -
Eternal Ltd
243.00 304.50(%) -
Reliance Infra.
346.80 350.90(%) -
Cochin Shipyard
1,900.55 1,180.45(%) -
SG Finserve
445.95 546.00(%) -
Bharat Dynamics
1,965.00 897.15(%) -
Bank of Maha
57.80 73.50(%) -
MMTC
77.42 42.55(%) -
Data Pattern
2,972.00 3,654.75(%) -
Reliance Industr
1,395.90 1,115.55(%) -
NBCC
127.25 139.83(%) -
Kotak Mah. Bank
2,051.30 1,602.20(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aurobindo Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 4666.0
- ISIN : INE406A01037
-
Today’s Low
1,144.30 -
Today’s High
1,174.00

-
Open
1,172.00 -
Perv Close
1,172.90 -
52W Low
1,010.00 -
52W High
1,592.00
Key Indicators
-
P/E(TTM)
38.49
-
Mar.Cap (₹Cr.)
67,254.03
-
Div & Yield %
0.00
-
Book Value(₹)
350.46
-
Debt-Equity Ratio
-2.14
-
AGM Date
30-May-2025
-
EPS
29.81
-
P/E Ratio
38.49
Financials Ratios
-
Debt-Equity Ratio
0.21
-
Mar.Cap (₹Cr.)
67,254.03
-
RONW (%)
11.18
-
ROCE (%)
13.51
Score Board
-
Equity (₹ in Cr.)
58.59
-
BV (₹)
350.50
-
Sales( ₹ in Cr.)
10,788.09
-
NP (in Cr.)
1,746.79
-
NP Var(%)
-11.0
-
Div%
0.0
-
CPS (₹)
34.90
-
EPS (₹)
29.80
-
Traded Value (₹ in Lakhs)
67,236.46
-
52 Week High
1,592.00
-
52 Week Low
1,010.00
-
Price BSE
1148.0
-
Price NSE
1,148.00
-
Market Capital( in Cr.)
67,236.46
-
P/C Ratio
32.90
-
P/E Ratio
38.50
-
Price Vs.BV
29.80
-
29-May-2025( 08:40)
Hot Pursuit - Aurob... - The purpose of the incorporati...
-
27-May-2025( 08:07)
Market Commentary - Stock Alert - Stock... - <b>Securities in F&O Ban:</b>...
-
27-May-2025( 07:41)
Results - Announcements - Aurob... - Net profit of Aurobindo Pharma...
-
17-May-2025( 04:08)
Corporate News - Aurob... - Aurobindo Pharma will hold a m...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 10,645.64 | 8,457.00 | 11,287.14 | 15,823.68 | 13,370.77 | 12,257.89 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 10,645.64 | 8,457.00 | 11,287.14 | 15,823.68 | 13,370.77 | 12,257.89 |
Other Income | 670.10 | 443.92 | 670.99 | 589.86 | 388.79 | 199.22 |
Stock Adjustments | 116.23 | 263.95 | -45.51 | -2.99 | 238.67 | 289.80 |
Total Income | 11,431.97 | 9,164.87 | 11,912.62 | 16,410.55 | 13,998.23 | 12,746.91 |
EXPENDITURE : | ||||||
Raw Materials | 5,964.48 | 4,755.95 | 5,800.74 | 7,241.83 | 6,819.85 | 6,469.55 |
Power and Fuel Cost | 191.58 | 167.86 | 477.99 | 512.34 | 526.31 | 505.96 |
Employee Cost | 980.56 | 890.53 | 1,600.04 | 1,735.42 | 1,577.14 | 1,362.77 |
Other Manufacturing Expenses | 414.51 | 328.42 | 705.68 | 925.86 | 814.44 | 795.13 |
Selling and Administration Expenses | 822.21 | 939.38 | 1,009.36 | 1,069.84 | 938.36 | 786.90 |
Miscellaneous Expenses | 164.49 | 148.96 | 249.13 | 215.57 | 235.47 | 218.09 |
Employee Benefit Expenses | 980.56 | 890.53 | 1,600.04 | 1,735.42 | 1,577.14 | 1,362.77 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 8,537.83 | 7,231.10 | 9,842.94 | 11,700.86 | 10,911.57 | 10,138.40 |
Operating Profit | 2,894.14 | 1,933.77 | 2,069.68 | 4,709.69 | 3,086.66 | 2,608.51 |
Interest | 182.60 | 74.58 | 16.94 | 28.68 | 243.28 | 230.86 |
Gross Profit | 2,711.54 | 1,859.19 | 2,052.74 | 4,681.01 | 2,843.38 | 2,377.65 |
Depreciation | 254.58 | 243.26 | 415.26 | 488.00 | 473.33 | 413.03 |
Profit Before Tax | 2,456.96 | 1,615.93 | 1,637.48 | 4,193.01 | 2,370.05 | 1,964.62 |
Current Tax | 598.08 | 412.16 | 379.70 | 1,043.34 | 492.28 | 378.56 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -95.26 | -23.34 | -196.93 | 36.76 | 0.89 | 56.33 |
Reported Net Profit | 1,954.14 | 1,227.11 | 1,454.71 | 3,112.91 | 1,876.88 | 1,529.73 |
Extraordinary Items | 1.17 | 9.94 | -81.27 | -0.13 | -1.90 | -8.01 |
Adjusted Net Profit | 1,952.97 | 1,217.17 | 1,535.98 | 3,113.04 | 1,878.78 | 1,537.74 |
Adjustment below Net Profit | -1.69 | 8.28 | 1.69 | -6.42 | -44.88 | 0.00 |
P & L Balance brought forward | 16,660.08 | 15,864.14 | 14,671.41 | 11,799.30 | 10,143.08 | 8,790.74 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 263.66 | 439.45 | 263.67 | 234.38 | 175.78 | 160.34 |
P & L Balance carried down | 18,348.87 | 16,660.08 | 15,864.14 | 14,671.41 | 11,799.30 | 10,160.13 |
Dividend | 263.66 | 439.45 | 0.00 | 0.00 | 0.00 | 146.48 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 450.00 | 750.00 | 900.00 | 400.00 | 300.00 | 250.00 |
Dividend Per Share(Rs) | 4.50 | 7.50 | 9.00 | 4.00 | 3.00 | 2.50 |
Earnings Per Share-Unit Curr | 33.35 | 20.94 | 24.83 | 53.13 | 32.03 | 26.11 |
Earnings Per Share(Adj)-Unit Curr | 33.35 | 20.94 | 24.83 | 53.13 | 32.03 | 26.11 |
Book Value | 336.62 | 307.80 | 292.15 | 271.80 | 222.78 | 193.73 |
Book Value(Adj)-Unit Curr | 336.62 | 307.80 | 292.15 | 271.80 | 222.78 | 193.73 |